Oncoprecision Corporation
Latest round
- Seed
Last raised
- Apr 2022
Total raised
- $3.3M
Investors
- 6
About Oncoprecision Corporation
Founded in 2020 and headquartered in New York, US, Oncoprecision Corporation is dedicated to developing therapeutic solutions in oncology. The company was founded by Candelaria De Los Ríos, Gastón Soria, Gerardo Gatti, and Tarek Zaki, who also serves as CEO.Oncoprecision is focused on developing novel therapeutic antibodies using a patient-centric approach in drug discovery. Their proprietary patient-derived models enhance the understanding of translational biology and improve success rates in drug development. Their product pipeline includes ONC001, an antibody-drug conjugate for monocytic leukemia, and ONC002, a bispecific antibody targeting tumor-associated macrophages.Oncoprecision generates revenue through strategic partnerships and collaborations with leading pharmaceutical companies and cancer centers. These collaborations typically involve licensing agreements that provide clients access to Oncoprecision’s proprietary models and therapeutic capabilities, structured around milestones and royalties. The company aims to expand its product offerings and explore new markets, particularly in North America and South America, by leveraging their innovative therapeutic models. Upcoming product launches are expected to enhance their portfolio and address critical needs in oncology.
Who invested in Oncoprecision Corporation
6 investors across 1 round
See all investors in Oncoprecision Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 1, 2022
Amount
$3.3M
Investors
Questions about Oncoprecision Corporation
Who invested in Oncoprecision Corporation?
Oncoprecision Corporation has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oncoprecision Corporation raised?
Oncoprecision Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oncoprecision Corporation last raise money?
Oncoprecision Corporation's most recent round on record is a Seed, in Apr 2022.
What does Oncoprecision Corporation do?
Founded in 2020 and headquartered in New York, US, Oncoprecision Corporation is dedicated to developing therapeutic solutions in oncology.
Where is Oncoprecision Corporation headquartered?
Oncoprecision Corporation is headquartered in New York, US.
Which VCs invest in companies like Oncoprecision Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oncoprecision Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Oncoprecision Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.